MiR-372-3p Promotes Preeclampsia Progression by Regulating Twist1

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2023 Jan 23

PMID 36686218

Authors

Ziwei Li

Jie Wang

Dianting Li

Haiying Chen

Tao Meng

Affiliations

Soon will be listed here.

Abstract

Preeclampsia (PE) is a common pregnancy-related disorder worldwide. PE is mainly characterized by the defective migration and invasion of trophoblast cells. MicroRNAs (miRs) have been reported to serve an important role in PE. The purpose of the study was to explore the pathogenesis and therapeutic targets of preeclampsia. In the present study, reverse transcription-quantitative PCR analysis revealed that the expression levels of miR-372-3p were upregulated in placental tissues from patients with PE. Notably, the expression levels of miR-372-3p were significantly upregulated in patients with early-onset PE compared with patients with late-onset PE. Moreover, analysis using wound healing, Transwell and western blotting assays demonstrated that miR-372-3p overexpression inhibited the migration, invasion and epithelial-mesenchymal transition (EMT) of HTR-8/SVneo trophoblast cells, respectively. Bioinformatics analysis and a dual luciferase reporter assay revealed that miR-372-3p is sponged by twist family bHLH transcription factor 1 (twist1). Rescue experiments found that miR-372-3p overexpression suppressed trophoblast cell migration, invasion and EMT by downregulating the expression of twist1. In conclusion, the present study revealed that high level of miR-372-3p may act as a factor to cause PE and may also be a potential novel therapeutic target for PE.

References

Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J . The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019; 18(1):4. PMC: 6325825. DOI: 10.1186/s12943-018-0933-7. View

Fan X, Huang X, Li Z, Ma X . MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway. J BUON. 2018; 23(5):1309-1315. View

DaSilva-Arnold S, Zamudio S, Al-Khan A, Alvarez-Perez J, Mannion C, Koenig C . Human trophoblast epithelial-mesenchymal transition in abnormally invasive placenta. Biol Reprod. 2018; 99(2):409-421. DOI: 10.1093/biolre/ioy042. View

Soliman M, Ragheb M, Elzayat E, Mohamed M, El-Ekiaby N, Abdelaziz A . MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma. Anticancer Agents Med Chem. 2020; 21(2):246-253. DOI: 10.2174/1871520620666200516145830. View

Beermann J, Piccoli M, Viereck J, Thum T . Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev. 2016; 96(4):1297-325. DOI: 10.1152/physrev.00041.2015. View

Sur S, Steele R, Shi X, Ray R . miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression. Cells. 2019; 8(11). PMC: 6912792. DOI: 10.3390/cells8111455. View

Lee C, Risom T, Strauss W . Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. DNA Cell Biol. 2007; 26(4):209-18. DOI: 10.1089/dna.2006.0545. View

Yang Y, Li H, Ma Y, Zhu X, Zhang S, Li J . MiR-221-3p is down-regulated in preeclampsia and affects trophoblast growth, invasion and migration partly via targeting thrombospondin 2. Biomed Pharmacother. 2018; 109:127-134. DOI: 10.1016/j.biopha.2018.10.009. View

Hansen T, Jensen T, Clausen B, Bramsen J, Finsen B, Damgaard C . Natural RNA circles function as efficient microRNA sponges. Nature. 2013; 495(7441):384-8. DOI: 10.1038/nature11993. View

10.

Tayyar A, Karakus R, Eraslan Sahin M, Topbas N, Sahin E, Karakus S . Wnt signaling pathway in early- and late-onset preeclampsia: evaluation with Dickkopf-1 and R-Spondin-3 glycoproteins. Arch Gynecol Obstet. 2019; 299(6):1551-1556. DOI: 10.1007/s00404-019-05126-8. View

11.

Cim N, Kurdoglu M, Ege S, Yoruk I, Yaman G, Yildizhan R . An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset.... J Matern Fetal Neonatal Med. 2016; 30(13):1602-1607. DOI: 10.1080/14767058.2016.1219986. View

12.

Wang Q, Liu S, Zhao X, Wang Y, Tian D, Jiang W . MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma. Cancer Med. 2017; 6(6):1323-1330. PMC: 5463061. DOI: 10.1002/cam4.1026. View

13.

Herzog E, Eggink A, Reijnierse A, Kerkhof M, de Krijger R, Roks A . Impact of early- and late-onset preeclampsia on features of placental and newborn vascular health. Placenta. 2016; 49:72-79. DOI: 10.1016/j.placenta.2016.11.014. View

14.

Li Y, Liu J, Zhou J, Chen R, Cen C . LncRNA HULC induces the progression of osteosarcoma by regulating the miR-372-3p/HMGB1 signalling axis. Mol Med. 2020; 26(1):26. PMC: 7081592. DOI: 10.1186/s10020-020-00155-5. View

15.

Chen D, Wang W . Human placental microRNAs and preeclampsia. Biol Reprod. 2013; 88(5):130. PMC: 4013914. DOI: 10.1095/biolreprod.113.107805. View

16.

Zhao G, Zhou X, Chen S, Miao H, Fan H, Wang Z . Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia. J Biomed Sci. 2014; 21:81. PMC: 4237795. DOI: 10.1186/s12929-014-0081-3. View

17.

von Dadelszen P, Magee L, Roberts J . Subclassification of preeclampsia. Hypertens Pregnancy. 2003; 22(2):143-8. DOI: 10.1081/PRG-120021060. View

18.

Shi J, Zhang Y, Jin N, Li Y, Wu S, Xu L . MicroRNA-221-3p Plays an Oncogenic Role in Gastric Carcinoma by Inhibiting PTEN Expression. Oncol Res. 2016; 25(4):523-536. PMC: 7841127. DOI: 10.3727/096504016X14756282819385. View

19.

Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

20.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View